cordelia

  HIV Diagnostics Market Overview HIV diagnostics market is expected to reach USD 4.1 Billion by 2030 and is projected to register a CAGR of 9.20% from 2023 to 2030. The market is predicted to develop due to factors like the rising global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the advantages provided by point-of-care tools and kits, and increased government initiatives. The study's base year was 2021, as well as the projection was made for the years 2020 through 2030. COVID-19 appears to have a significant impact on the HIV Diagnostics Market . The human immunodeficiency virus (HIV) targets the human body's immune system. Hiv - Infected people can receive antiretroviral medication and live a long and healthy life. The firm's demand will be fueled by the availability of several HIV diagnostic tests. HIV Diagnostics Market Segmentation By Product Consumables: The need for consumable products for each test is the fastest

  Medical Telemetry Market Highlights The medical telemetry market is projected to reach USD 81.47 Million by 2030 at 13.90% CAGR during the forecast period 2022-2030. The global medical telemetry market is expected to witness tremendous growth owing to the information and communication technology or ICT, advancement in mobile perforation, and connectivity in the region is driving the growth of the medical telemetry market. Other factors such as the advent of various new-age facilities such as mHealth , virtual visits, and tele-ICUs. The industry players such as InTouch Health, iRobot, and Vecna Technologies have developed robots that serve as the physician's stand-in in remote clinics, which are the key factor driving the growth of the segment. However, factors such as low awareness about telemetry in the emerging region are expected to curb the growth of the market during the forecast period. Segmentation The global medical telemetry market report is segmented based o

  Pain Relief Medication Market Highlights Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain. The global pain relief medication market growth is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market. Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) for the management

  Asthma and COPD Drugs Market Highlights The Asthma and COPD Drugs Market is projected to reach USD 34,374.23 Million by 2030 at 4.20% CAGR during the forecast period 2022-2030. Asthma is a type of inflammatory disease that affects the lungs and makes breathing difficult. It is one of the common chronic conditions affecting many people across the globe. COPD or chronic obstructive pulmonary disease is an umbrella term used for a group of respiratory diseases such as emphysema and chronic bronchitis. Regional Analysis Global asthma and COPD drugs market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are likely to dominate global asthma and COPD drugs market. This can be attributed to the rising patient population suffering from asthma and COPD in the region. According to the American Academy of Allergy Asthma & Immunology, in 2016, approximately 8.3% of children in the US had asthma. Moreover, the

  Plasma Therapy Market Highlights According to MRFR analysis, the global plasma therapy market is expected to cross USD 895.45 million by 2030 at a CAGR of 13.8%. The global plasma therapy market is driven by several factors, such as the growing prevalence of immune deficiency disorders, autoimmune disorders, bleeding disorders and rising acceptance of plasma therapy in neurology and other therapeutic indications. The surge in the adoption of therapeutic protein drugs in the cure of a broad range of clinical symptoms. This is expected to rise as a potential for the market during the forecast period. Approvals around the globe for new plasma-derived therapies will increase the demand. Thus, the above-mentioned factors are anticipated to surge the growth of the global plasma therapy market soon. Technological advancements in the field and rising awareness among the population regarding the disease and availability of the treatment are pushing the market to new heights. Plasma the

  Prefilled Syringes Market Overview Prefilled Syringes Market Size was valued at USD 79.5 billion in 2022. The Prefilled Syringes market industry is projected to grow from USD 83.6 Billion in 2023 to USD 112.8 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period (2023 - 2030) . The minimal drug wastage achieved through the increased in the utility of prefilled syringes has opened an attractive option for the growing pharmaceutical sector to invest. This is expected to promote the prefilled syringe market in the study period. The benefit of self-administration of medication offered by these syringes has increased its consumer based, thereby contributing to the overall growth of the prefilled syringe market. The biologics and biosimilars sectors are observed as another major promoters of the prefilled syringe market. Other causes that are expected to propel the prefilled syringe Prefilled Syringes Market are persistence of chronic dis

  Traumatic Brain Injuries Treatment Market Highlights: Traumatic brain injury (TBI) occurs from a violent blow or head injury that disturb the normal functioning of the brain. Every year TBI contributes to a substantial number of death and permanent disability. Elder age population holds the largest share of global traumatic brain injuries treatment market due to increasing incidence of road accident and high rate of hospitalization and is expected to grow staidly during the forecast period. Whereas based on treatment, medication (drug) segment holds the highest share of this market. Increasing incidences of road traffic injury and the government initiatives to fund for traumatic brain injuries project will boost the traumatic brain injuries treatment market during assessment period. Traumatic Brain Injuries Treatment market is projected to reach USD 2,900 Million by 2030 at 8.50% CAGR during the forecast period 2022-2030. However, high cost of treatment and devices may hamper